StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.39−0.03 (-7.14%)

Close on Nov 16, 2026Market cap $2.02MP/E –Yield –

Jaguar Health r&d expenses

Research and development expenses are spending on new products and technology.

Jaguar Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $25.24M, up 62.1% year over year. For fiscal 2025 it was $24.97M, up 50.9% from the year before. Over ten years it grew 14.4% a year on average. The highest annual figure on record is $24.97M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.97M+50.9%
FY2024Dec 31, 2024$16.54M-11.0%
FY2023Dec 31, 2023$18.60M+5.4%
FY2022Dec 31, 2022$17.65M+17.0%
FY2021Dec 31, 2021$15.08M+135.1%
FY2020Dec 31, 2020$6.41M+10.2%
FY2019Dec 31, 2019$5.82M+12.9%
FY2018Dec 31, 2018$5.15M+20.7%
FY2017Dec 31, 2017$4.27M-40.8%
FY2016Dec 31, 2016$7.21M+11.3%
FY2015Dec 31, 2015$6.48M+53.4%
FY2014Dec 31, 2014$4.22M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.34M+2.2%
Q1 FY2026Mar 31, 2026$3.93M+5.3%
Q4 FY2025Dec 31, 2025$14.31M+215.7%
Q3 FY2025Sep 30, 2025$3.66M-9.5%
Q2 FY2025Jun 30, 2025$3.27M-10.6%
Q1 FY2025Mar 31, 2025$3.73M-13.5%
Q4 FY2024Dec 31, 2024$4.53M+30.9%
Q3 FY2024Sep 30, 2024$4.04M-33.5%
Q2 FY2024Jun 30, 2024$3.65M-14.6%
Q1 FY2024Mar 31, 2024$4.31M-9.7%
Q4 FY2023Dec 31, 2023$3.46M-19.7%
Q3 FY2023Sep 30, 2023$6.08M+2.4%
Q2 FY2023Jun 30, 2023$4.28M+74.5%
Q1 FY2023Mar 31, 2023$4.78M-3.4%
Q4 FY2022Dec 31, 2022$4.31M-21.4%
Q3 FY2022Sep 30, 2022$5.94M+79.3%
Q2 FY2022Jun 30, 2022$2.45M-36.7%
Q1 FY2022Mar 31, 2022$4.95M+104.8%
Q4 FY2021Dec 31, 2021$5.48M+187.9%
Q3 FY2021Sep 30, 2021$3.31M+117.6%
Q2 FY2021Jun 30, 2021$3.87M+175.4%
Q1 FY2021Mar 31, 2021$2.41M+52.6%
Q4 FY2020Dec 31, 2020$1.90M+36.6%
Q3 FY2020Sep 30, 2020$1.52M+16.4%
Q2 FY2020Jun 30, 2020$1.41M-17.3%
Q1 FY2020Mar 31, 2020$1.58M+11.3%
Q4 FY2019Dec 31, 2019$1.39M+6.3%
Q3 FY2019Sep 30, 2019$1.31M-11.8%
Q2 FY2019Jun 30, 2019$1.70M+37.4%
Q1 FY2019Mar 31, 2019$1.42M+66.9%
Q4 FY2018Dec 31, 2018$1.31M+41.4%
Q3 FY2018Sep 30, 2018$1.48M+18.0%
Q4 FY2017Dec 31, 2017$1.24M-19.5%
Q3 FY2017Sep 30, 2017$851.61K-56.7%
Q2 FY2017Jun 30, 2017$926.79K-52.6%
Q1 FY2017Mar 31, 2017$1.26M–
Q4 FY2016Dec 31, 2016$1.53M–
Q3 FY2016Sep 30, 2016$1.97M–
Q2 FY2016Jun 30, 2016$1.95M–

More Jaguar Health figures

See a number that looks wrong?